Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
The American Journal of Cardiology
|
July 22, 1998
Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia
K Kajinami, K Yagi, T Higashikata, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 14, 1999
Abetalipoproteinemia caused by maternal isodisomy of chromosome 4q containing an intron 9 splice acceptor mutation in the microsomal triglyceride transfer protein gene
X P Yang, A Inazu, K Yagi, et al.
Atherosclerosis
|
September 1, 1992
Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia
T Takegoshi, T Haba, C Kitoh, et al.
Journal of Biochemistry
|
March 1, 1994
Stereospecificity of trans-dihydrodiol oxidation by dimeric and monomeric dihydrodiol dehydrogenases from mammalian tissues
S Yamaguchi, A Inazu, Y Deyashiki, et al.
The American Journal of Cardiology
|
October 12, 2000
Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia
M Kawashiri, K Kajinami, A Nohara, et al.
Annals of the New York Academy of Sciences
|
January 17, 1995
Molecular genetics of cholesterol transport and cholesterol reverse transport disorders (familial hypercholesterolemia and CETP deficiency) and coronary heart disease
H Mabuchi, K Yagi, T Haraki, et al.
Archives of Biochemistry and Biophysics
|
December 1, 1993
Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase
K Sato, A Inazu, S Yamaguchi, et al.
Atherosclerosis
|
February 24, 2001
Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia
T Nozue, A Nohara, T Higashikata, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 6, 1998
Enzyme immunoassay for cholesteryl ester transfer protein in human serum
T Kiyohara, R Kiriyama, S Zamma, et al.
Atherosclerosis
|
November 1, 1988
Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system
J Koizumi, A Inazu, H Fujita, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
The American Journal of Cardiology
|
July 22, 1998
Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia
K Kajinami, K Yagi, T Higashikata, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 14, 1999
Abetalipoproteinemia caused by maternal isodisomy of chromosome 4q containing an intron 9 splice acceptor mutation in the microsomal triglyceride transfer protein gene
X P Yang, A Inazu, K Yagi, et al.
Atherosclerosis
|
September 1, 1992
Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia
T Takegoshi, T Haba, C Kitoh, et al.
Journal of Biochemistry
|
March 1, 1994
Stereospecificity of trans-dihydrodiol oxidation by dimeric and monomeric dihydrodiol dehydrogenases from mammalian tissues
S Yamaguchi, A Inazu, Y Deyashiki, et al.
The American Journal of Cardiology
|
October 12, 2000
Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia
M Kawashiri, K Kajinami, A Nohara, et al.
Annals of the New York Academy of Sciences
|
January 17, 1995
Molecular genetics of cholesterol transport and cholesterol reverse transport disorders (familial hypercholesterolemia and CETP deficiency) and coronary heart disease
H Mabuchi, K Yagi, T Haraki, et al.
Archives of Biochemistry and Biophysics
|
December 1, 1993
Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase
K Sato, A Inazu, S Yamaguchi, et al.
Atherosclerosis
|
February 24, 2001
Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia
T Nozue, A Nohara, T Higashikata, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 6, 1998
Enzyme immunoassay for cholesteryl ester transfer protein in human serum
T Kiyohara, R Kiriyama, S Zamma, et al.
Atherosclerosis
|
November 1, 1988
Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system
J Koizumi, A Inazu, H Fujita, et al.
Page
of 6